View Item 

Show simple item record

Pseudosarcomatous myofibroblastic proliferations of the genitourinary tract are genetically different from nodular fasciitis and lack USP6, ROS1 and ETV6 gene rearrangements
dc.contributor.authorJebastin, Judith A S
dc.contributor.authorSmith, Steven C
dc.contributor.authorPerry, Kyle D
dc.contributor.authorGupta, Nilesh S
dc.contributor.authorAlanee, Shaheen
dc.contributor.authorCarskadon, Shannon
dc.contributor.authorChitale, Dhananjay A
dc.contributor.authorPalanisamy, Nallasivam
dc.contributor.authorWilliamson, Sean R
dc.date.accessioned2018-08-13T18:49:48Z
dc.date.available2019-10-01T16:02:10Zen
dc.date.issued2018-08
dc.identifier.citationJebastin, Judith A S; Smith, Steven C; Perry, Kyle D; Gupta, Nilesh S; Alanee, Shaheen; Carskadon, Shannon; Chitale, Dhananjay A; Palanisamy, Nallasivam; Williamson, Sean R (2018). "Pseudosarcomatous myofibroblastic proliferations of the genitourinary tract are genetically different from nodular fasciitis and lack USP6, ROS1 and ETV6 gene rearrangements." Histopathology 73(2): 321-326.
dc.identifier.issn0309-0167
dc.identifier.issn1365-2559
dc.identifier.urihttps://hdl.handle.net/2027.42/145266
dc.publisherIARC Press
dc.publisherWiley Periodicals, Inc.
dc.subject.otherinflammatory myofibroblastic tumour
dc.subject.otherpseudosarcomatous myofibroblastic proliferation
dc.subject.othersoft tissue tumours
dc.subject.otherurinary bladder
dc.subject.otherUSP6
dc.titlePseudosarcomatous myofibroblastic proliferations of the genitourinary tract are genetically different from nodular fasciitis and lack USP6, ROS1 and ETV6 gene rearrangements
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMicrobiology and Immunology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/145266/1/his13526_am.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/145266/2/his13526.pdf
dc.identifier.doi10.1111/his.13526
dc.identifier.sourceHistopathology
dc.identifier.citedreferenceIczkowski KA, Shanks JH, Gadaleanu V et al. Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty‐eight spindle cell neoplasms. Mod. Pathol. 2001; 14; 1043 – 1051.
dc.identifier.citedreferenceHarik LR, Merino C, Coindre JM, Amin MB, Pedeutour F, Weiss SW. Pseudosarcomatous myofibroblastic proliferations of the bladder: a clinicopathologic study of 42 cases. Am. J. Surg. Pathol. 2006; 30; 787 – 794.
dc.identifier.citedreferenceMontgomery EA, Shuster DD, Burkart AL et al. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high‐grade urothelial carcinoma. Am. J. Surg. Pathol. 2006; 30; 1502 – 1512.
dc.identifier.citedreferenceTsuzuki T, Magi‐Galluzzi C, Epstein JI. ALK‐1 expression in inflammatory myofibroblastic tumor of the urinary bladder. Am. J. Surg. Pathol. 2004; 28; 1609 – 1614.
dc.identifier.citedreferenceCheng L, Foster SR, MacLennan GT, Lopez‐Beltran A, Zhang S, Montironi R. Inflammatory myofibroblastic tumors of the genitourinary tract—single entity or continuum? J. Urol. 2008; 180; 1235 – 1240.
dc.identifier.citedreferenceHirsch MS, Dal Cin P, Fletcher CD. ALK expression in pseudosarcomatous myofibroblastic proliferations of the genitourinary tract. Histopathology 2006; 48; 569 – 578.
dc.identifier.citedreferenceWilliamson SR, Lopez‐Beltran A, MacLennan GT, Montironi R, Cheng L. Unique clinicopathologic and molecular characteristics of urinary bladder tumors in children and young adults. Urol. Oncol. 2013; 31; 414 – 426.
dc.identifier.citedreferenceLott S, Lopez‐Beltran A, Maclennan GT, Montironi R, Cheng L. Soft tissue tumors of the urinary bladder, Part I: myofibroblastic proliferations, benign neoplasms, and tumors of uncertain malignant potential. Hum. Pathol. 2007; 38; 807 – 823.
dc.identifier.citedreferenceErickson‐Johnson MR, Chou MM, Evers BR et al. Nodular fasciitis: a novel model of transient neoplasia induced by MYH9–USP6 gene fusion. Lab. Invest. 2011; 91; 1427 – 1433.
dc.identifier.citedreferenceYamamoto H, Yoshida A, Taguchi K et al. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours. Histopathology 2016; 69; 72 – 83.
dc.identifier.citedreferenceCook JR, Dehner LP, Collins MH et al. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am. J. Surg. Pathol. 2001; 25; 1364 – 1371.
dc.identifier.citedreferenceChoi E, Williamson SR, Montironi R et al. Inflammatory myofibroblastic tumour of the urinary bladder: the role of immunoglobulin G4 and the comparison of two immunohistochemical antibodies and fluorescence in‐situ hybridization for the detection of anaplastic lymphoma kinase alterations. Histopathology 2015; 67; 20 – 38.
dc.identifier.citedreferenceAlquati S, Gira FA, Bartoli V, Contini S, Corradi D. Low‐grade myofibroblastic proliferations of the urinary bladder. Arch. Pathol. Lab. Med. 2013; 137; 1117 – 1128.
dc.identifier.citedreferenceHojo H, Newton WA Jr, Hamoudi AB et al. Pseudosarcomatous myofibroblastic tumor of the urinary bladder in children: a study of 11 cases with review of the literature. An Intergroup Rhabdomyosarcoma Study. Am. J. Surg. Pathol. 1995; 19; 1224 – 1236.
dc.identifier.citedreferenceCabillic F, Gros A, Dugay F et al. Parallel FISH and immunohistochemical studies of ALK status in 3244 non‐small‐cell lung cancers reveal major discordances. J. Thorac. Oncol. 2014; 9; 295 – 306.
dc.identifier.citedreferenceRo JY, el‐Naggar AK, Amin MB, Sahin AA, Ordonez NG, Ayala AG. Pseudosarcomatous fibromyxoid tumor of the urinary bladder and prostate: immunohistochemical, ultrastructural, and DNA flow cytometric analyses of nine cases. Hum. Pathol. 1993; 24; 1203 – 1210.
dc.identifier.citedreferenceLazar A, Evans HL, Oliveira AM. Nodular fasciitis. In Fletcher CDM, Bridge JA, Hogendoorn PC, Mertens F eds. World Health Organization classification of tumours of soft tissue and bone. Lyon: IARC Press, 2013; 46 – 47.
dc.identifier.citedreferenceKoirala TR, Hayashi K, Ohara N et al. Inflammatory pseudotumor of the urinary bladder with an aberrant expression of cytokeratin. Pathol. Int. 1994; 44; 73 – 79.
dc.identifier.citedreferenceShin C, Low I, Ng D, Oei P, Miles C, Symmans P. USP6 gene rearrangement in nodular fasciitis and histological mimics. Histopathology 2016; 69; 784 – 791.
dc.identifier.citedreferenceOliveira AM, Perez‐Atayde AR, Dal Cin P et al. Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes. Oncogene 2005; 24; 3419 – 3426.
dc.identifier.citedreferenceAlbores‐Saavedra J, Manivel JC, Essenfeld H et al. Pseudosarcomatous myofibroblastic proliferations in the urinary bladder of children. Cancer 1990; 66; 1234 – 1241.
dc.identifier.citedreferenceWirman JA. Nodular fasciitis, a lesion of myofibroblasts: an ultrastructural study. Cancer 1976; 38; 2378 – 2389.
dc.identifier.citedreferenceSanfrancesco J, McKenney JK, Leivo MZ, Gupta S, Elson P, Hansel DE. Sarcomatoid urothelial carcinoma of the bladder: analysis of 28 cases with emphasis on clinicopathologic features and markers of epithelial‐to‐mesenchymal transition. Arch. Pathol. Lab. Med. 2016; 140; 543 – 551.
dc.identifier.citedreferenceWestfall DE, Folpe AL, Paner GP et al. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder. Am. J. Surg. Pathol. 2009; 33; 99 – 105.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
his13526_am.pdf
Size:
141.9KB
Format:
PDF
View/Open
Name:
his13526.pdf
Size:
678.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.